IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Gut

• Publication date

  1987-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.28.4.474PMID 3583074PMCID PMC1432811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The OMGE multinational inflammatory bowel disease survey 1976-1986. A further report on 3175 cases.

  1988cited by this paper
• The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases.

  1984cited by this paper
• An index of inflammatory activity in patients with Crohn's disease.

  1984cited by this paper
• The Crohn’s Disease Activity Index as a Clinical Instrument

  1981cited by this paper
• An index of inflammatory activity in patients with Crohn's disease.

  1980cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper
• Measures of association for cross classifications

  1979cited by this paper
• National Cooperative Crohn's Disease Study: study design and conduct of the study.

  1979cited by this paper
• Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

  1976cited by this paper
• Observations on the probability of error in medical diagnosis.

  1962cited by this paper
• A Coefficient of Agreement for Nominal Scales

  1960cited by this paper
• Nonlinear Prediction and Dynamics

  1956cited by this paper
• Reliability of Content Analysis ; The Case of Nominal Scale Cording

  1955cited by this paper

• Methotrexate in the management of Crohn’s disease: A practice survey of gastroenterologists in France

  2025cites this paper
• Patient-Reported Outcomes in Colorectal Surgery

  2023cites this paper
• Serum leucine‐rich alpha‐2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease

  2022cites this paper
• Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient's perspective: IBD-Control, EII-Control

  2022cites this paper
• Diagnosis of Inflammatory Bowel Disease by Abdominal ultrasound and Color Doppler Techniques.

  2021cites this paper
• Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient´s perspective: IBD-control, EII-control.

  2021cites this paper
• Crohn’s Disease Activity Index

  2020cites this paper
• Week 6 Calprotectin Best Predicts Likelihood of Long-Term Endoscopic Healing in Crohn's Disease: A Post-Hoc Analysis of the UNITI/IM-UNITI Trials.

  2020cites this paper
• End of Induction Patient Reported Outcomes Predict Clinical Remission but not Endoscopic Remission in Crohn's Disease.

  2020cites this paper
• The IBD Control Questionnaire: the development and psychometric validation of a questionnaire for measuring inflammatory bowel disease control from the patient's perspective.

  2019cites this paper
• Evolution of treatment targets in Crohn's disease.

  2019cites this paper
• Editor’s Pick: Identifying Shared Features and Addressing Common Challenges in Clinical Trials for Chronic Inflammatory Diseases: An Overview

  2019cites this paper
• Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study

  2019cites this paper
• Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

  2018cites this paper
• Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity.

  2018cites this paper
• Identifying disease-specific distress in patients with inflammatory bowel disease.

  2016cites this paper
• Contrast-enhanced Ultrasound for Detection of Crohn's Disease Activity: Systematic Review and Meta-analysis.

  2016cites this paper
• Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn's Disease

  2016cites this paper
• Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan

  2016cites this paper
• Plasma osteopontin predicts inflammatory bowel disease activities.

  2015cites this paper
• Plateletcrit: A sensitive biomarker for evaluating disease activity in Crohn's disease with low hs‐CRP

  2015cites this paper
• Hypocalcemia secondary to hypomagnesemia in a patient with Crohn’s disease

  2015cites this paper
• Biological markers demonstrate utility and predictive value in inflammatory bowel disease

  2015influential citation
• Early vitamin K deficiency bleeding in a neonate associated with maternal Crohn’s disease

  2014cites this paper
• The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

  2013cites this paper
• Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-Control questionnaire

  2013cites this paper
• Plasma Citrulline Concentration as a Marker for Disease Activity in Patients With Crohn’s Disease

  2012cites this paper
• Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

  2012cites this paper
• Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

  2012cites this paper
• Effects of family history on inflammatory bowel disease characteristics in Japanese patients

  2012cites this paper
• Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: A 3‐year prospective randomized open trial

  2012cites this paper
• Decrease of Peripheral and Intestinal NKG2A-Positive T Cells in Patients with Ulcerative Colitis

  2012cites this paper
• Endoscopic monitoring of infliximab therapy in Crohn's disease

  2011cites this paper
• Successful Medical Management of Multilocular Psoas Abscess in a Pregnant Woman with Crohn’s Disease: A Case Report

  2011cites this paper
• Validating Crohn's disease activity indices for use in assessing postoperative recurrence

  2011cites this paper
• Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn’s disease: a multicenter experience

  2010cites this paper
• Teduglutide, a novel mucosally active analog of glucagon‐like peptide‐2 (GLP‐2) for the treatment of moderate to severe Crohn's disease

  2010cites this paper
• Assessment of Growth Disturbance in Japanese Children with IBD

  2010cites this paper
• Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan

  2010cites this paper
• Circulating Cytokines Reflect Mucosal Inflammatory Status in Patients with Crohn’s Disease

  2010cites this paper
• Nephrolithiasis as an extra-intestinal presentation of pediatric inflammatory bowel disease unclassified.

  2010cites this paper
• Infliximabe na doença de crohn: experiência clínica de um centro terciário paulista

  2009cites this paper
• Human neutrophil peptides 1–3 are useful biomarkers in patients with active ulcerative colitis

  2009cites this paper
• Scores clinicobiologiques de la maladie de Crohn

  2009cites this paper
• Factors predicting the outcome of disease activity assessment in Crohn's disease

  2009cites this paper
• Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease

  2009cites this paper
• Should enteral nutrition be considered as primary therapy in acute Crohn's disease?

  2009cites this paper
• Increased Expression of Long Pentraxin PTX3 in Inflammatory Bowel Diseases

  2008cites this paper
• Urinary neopterin is a valuable tool in monitoring Crohn's disease activity

  2008cites this paper
• C-reactive protein as a valuable marker of the clinical activity of Crohn’s disease

  2008cites this paper
• Clinical Indices for Pediatric Inflammatory Bowel Disease Research

  2008cites this paper
• Use of the Crohn's disease activity index in clinical trials of biological agents.

  2008cites this paper
• Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.

  2007cites this paper
• What predicts mucosal inflammation in Crohn's disease patients?

  2007cites this paper
• C-reactive protein as a valuable marker of the clinical activity of Crohn's disease Bia³ko C-reaktywne jako marker aktywnoœci klinicznej w chorobie Leœniowskiego-Crohna

  2007cites this paper
• Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase

  2006cites this paper
• Anti-calreticulin antibodies in patients with inflammatory bowel disease.

  2006cites this paper
• The use of electrogastrography and external ultrasonography to evaluate gastric motility in Crohn's disease.

  2006cites this paper
• Indices de actividad en la enfermedad de Crohn. Revisión crítica y evaluación de su utilidad en el manejo clínico

  2005cites this paper
• A Review of Activity Indices and End Points for Clinical Trials in Children with Crohn's Disease

  2005cites this paper
• Faecal calprotectin in the assessment of Crohn's disease activity.

  2005cites this paper
• A Survey of Methodological Variation in the Crohn's Disease Activity Index

  2005cites this paper
• Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital

  2004cites this paper
• Psoas abscess complicating Crohn's disease: Report of two cases

  2004cites this paper
• Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study

  2004cites this paper
• Postpartum amenorrhoea-galactorrhoea associated with hyperprolactinaemia and pituitary enlargement in primary hypothyroidism.

  2004cites this paper
• Distinct Elevation of Levels of Anti-Caenorhabditis elegans Antibody in Sera of Patients with Inflammatory Bowel Disease

  2003cites this paper
• Metronidazole plus ciprofloxacin therapy for active Crohn's disease.

  2003cites this paper
• Review article: Crohn's disease: monitoring disease activity.

  2003cites this paper
• Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials.

  2003cites this paper
• Comparison between Prospective and Retrospective Evaluation of Crohn's Disease Activity Index

  2003cites this paper
• Crohn's disease: monitoring disease activity

  2003cites this paper
• 重症Crohn病の経過中, 肝不全により死の転帰をとったnonalcoholic steatohepatitisの1例

  2003cites this paper
• Assessing disease activity and disease activity indices for inflammatory bowel disease

  2002cites this paper
• A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

  2002cites this paper
• Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.

  2001cites this paper
• Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials.

  2001cites this paper
• Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor‐α for Crohn's disease in Japan: Evaluation by rapid turnover proteins, and radiologic and endoscopic findings

  2001cites this paper
• Symptoms Associated with Gastroesophageal Reflux Disease

  2001cites this paper
• Infliximab for Crohn's disease: more questions than answers.

  2001cites this paper
• E-selectin in Plasma and Colonic Mucosa of Patients with Crohn's Disease

  2000cites this paper
• The relationship of health beliefs knowledge of disease and social support to health-related quality of life in patients with inflammatory bowel disease

  2000cites this paper
• "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.

  1999cites this paper
• Assessing activity of pediatric Crohn's disease: which index to use?

  1999cites this paper
• The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn's disease.

  1999cites this paper
• Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease.

  1999cites this paper
• An Evaluation of Quality of Life in Outpatients with Crohn's Disease

  1999cites this paper
• Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.

  1999cites this paper
• Markers of Coagulation and Fibrinolysis as Measures of Disease Activity in Inflammatory Bowel Disease

  1998cites this paper
• Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.

  1998cites this paper
• Universal Skew of T Cell Receptor (TCR) Vβ Usage for Crohn's Disease (CrD)

  1997cites this paper
• Review article: the dietary management of Crohn's disease

  1997cites this paper
• Universal skew of T cell receptor (TCR) V beta usage for Crohn's disease (CrD).

  1997cites this paper
• Psoas abscess complicating Crohn’s disease: Report of a case

  1996cites this paper
• Drug related hospital admissions in subspecialities of internal medicine.

  1996cites this paper
• Review article: quantitative leucocyte scanning in the assessment of inflammatory bowel disease activity and its response to therapy

  1996cites this paper
• Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss.

  1996cites this paper
• Outcome of Maintenance Therapy in Crohn's Disease

  1996cites this paper
• Correlation of various Crohn's disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics.

  1996cites this paper
• Assessment of Disease Activity in Ulcerative Colitis and Crohn's Disease

  1995cites this paper